Lab: Ferritin 3 (13-171), TIBC: 451 (224-435)
Molecular test: JAK2 V617F mutation negative
JAK2 exon 12 mutation detected
Diagnosis: Polycythemia Vera
Molecular test: JAK2 V617F mutation negative
JAK2 exon 12 mutation detected
Diagnosis: Polycythemia Vera
Arber DA, Orazi A, Hasserjian, R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127(20): 2391-2405
JAK2V617F mutation in 95% of the cases, JAK2 exon 12 mutation in 5%. Exon 12 mutation may show predominance of erythroid proliferation in BM.
JAK2V617F mutation in 95% of the cases, JAK2 exon 12 mutation in 5%. Exon 12 mutation may show predominance of erythroid proliferation in BM.
![Picture](/uploads/2/5/3/2/25327069/pv2.jpg?250)